AgingResearch.News
Journal of Clinical Lipidology

Single-dose ION775, a GalNAc-conjugated siRNA targeting APOC3, lowers triglycerides for up to 12 months in moderate hypertriglyceridemia

By Sotirios Tsimikas, Erin Morgan, Jyoti Sharma, Show 4 more authorsThomas A Prohaska
Trial in peopleInterventions
Paper

The paper

Sotirios Tsimikas, Erin Morgan, Jyoti Sharma, Show 4 more authorsThomas A Prohaska

Ionis Pharmaceuticals (United States)

Journal of Clinical Lipidology, 28 Aug 2026

doi.org/10.1016/j.jacl.2026.08.012PubMed 42660799

More in Interventions